摘要
支气管哮喘是由多种细胞包括气道的炎性细胞和结构细胞以及细胞组分参与的气道慢性炎症性疾病,吸入疗法治疗哮喘的效果最为显著,作用直接,全身毒副作用较少,起效快,且有效用药量小,使用吸入疗法的关键在于药物可直接吸入到达肺内。
Bronchial asthma is caused by a variety of cells including airway inflammatory and structural cells and cellular components involved in chronic inflammatory airway disease, inhalation therapy in the treatment of asthma is the most significant, direct action, the systemic toxicity and fewer side effects, fast onset of action, and the effective dosage is small, the use of inhaled therapy is the key to drug can be directly sucked to lung.
出处
《中国医学创新》
CAS
2013年第23期159-162,共4页
Medical Innovation of China
关键词
支气管哮喘
吸入疗法
Bronchial asthma
Inhaled therapy
